PAIN RESEARCH & Drug development
Dr. Yeomans’ research has focused on investigating the pathophysiology and treatment of pain. As Pain Research Director, he brings together scientists and clinicians from diverse fields to focus on critically important areas of pain research. Dr. Yeomans’ laboratory has focused on distinguishing the science underlying different types of pain, identifying markers of these different pain types, and developing novel therapeutics targeted toward these distinct pain types. He has studied the differential biology of pain mediated by the activation of myelinated vs. unmyelinated pain-sensing nerves. His work in therapeutic development has focused primarily on voltage-gated sodium channels and nasally applied oxytocin. In addition to his work on pain, Dr. Yeomans has focused recently on designing drugs that can manipulate transcription factors for the treatment of numerous diseases, including neurodegenerative disorders, several types of cancer, and metabolic disorders.
Expertise
- Investigating the pathophysiology and treatment of pain.
- Distinguishing the science underlying different types of pain.
- Identifying markers of different pain types.
- Development of novel therapeutics targeted toward distinct pain types.
- Differential biology of pain mediated by the activation of myelinated vs. unmyelinated pain sensing nerves.
- Voltage-gated sodium channels and nasally applied oxytocin.
- Designing drugs that can manipulate transcription factors for the treatment of numerous diseases.
Experience
- Director of Pain Research at Stanford University.
- Director, Neuroscience Scholarly Concentration.
- Professor, Department of Anesthesiology, Perioperative, and Pain Medicine.
- Member, Stanford Bio-X and Stanford Neuroscience Institute.
- Pfizer Professor of Pain Medicine.
- Author of more than 130 papers and 11 book chapters on the subject of pain.
- Inventor on 13 US patents and applications.
- Founded three privately-funded biotechnology companies.